Skip to main content
Clinical Trials/CTRI/2024/01/061829
CTRI/2024/01/061829
Not yet recruiting
未知

Development of screening tool to identify fatal hyperinflammatory subphenotype-2 of acute respiratory distress syndrome (ARDS) with Point-of-Care Ultrasound, ventilatory mechanical power, and blood cell count-derived biomarkers. - Nil

SHWETHAPRIYA R0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: J80- Acute respiratory distress syndrome
Sponsor
SHWETHAPRIYA R
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational

Investigators

Sponsor
SHWETHAPRIYA R

Eligibility Criteria

Inclusion Criteria

  • Adult ARDS patients as per Berlin criteria

Exclusion Criteria

  • Patients with ARDS diagnosis \> 24 hours.
  • Patients of ARDS, not on IMV.
  • Lung trauma, chest wall deformities where POCUS may be unreliable.
  • Previously known causes of right ventricular dysfunction.
  • Patients on previous corticosteroids where NLR, SIII ratio will be unreliable.
  • Patients with known CKD where Renal arterial Resistive Index (RII) will be unreliable.

Outcomes

Primary Outcomes

Not specified

Similar Trials